24th January 2022
$2.8m MRFF boost for vital cancer immunotherapy research
Mater Research will begin trialing a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8m grant
Latest News
9 June 2021
Immune cells found to attack melanoma
Prof Gabrielle Belz and her team discovered a type of immune cells can halt the rapid development of melanoma
More about Immune cells found to attack melanoma
7 June 2021
3D-printed kidney model proves effective as hands-on education tool
ACCISS has developed a 3D-printed kidney model as a hands-on education tool for A&TSI patients
More about 3D-printed kidney model proves effective as hands-on education tool
6 June 2021
Funding for Translational Manufacturing Institute
Queensland Government announces funding support for the Translational Manufacturing Institute at TRI
More about Funding for Translational Manufacturing Institute 
31 May 2021
Vaccine response linked to hormone
TRI-based Prof Di Yu and his team have discovered the metabolic hormone, leptin, can influence the body's response to vaccines.
More about Vaccine response linked to hormone
13 May 2021
AI opening new fields for cancer researchers
Dr Pascal Duijf is using AI to unearth potential new treatments for cancers
More about AI opening new fields for cancer researchers 
10 May 2021
UQDI RESEARCHERS FIND NEW WAY TO REDUCE SCARRING
Prof Kiarash Khosrotehrani and his team discover molecule target to reduce scarring.
More about UQDI RESEARCHERS FIND NEW WAY TO REDUCE SCARRINGPages
Events
21 March 2022 9:30 AM – 6:00 PM
ASSC Genetics Summit 21 March 2022
The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit
More about ASSC Genetics Summit 21 March 2022 Upcoming Events
Sorry, no results found
Please try again with less restrictive search criteria
